Please join IPI for this important virtual policy briefing on the issues surrounding the pharmaceutical industry, and why we must not allow runaway populism to endanger one of our most critical industries.

Please join the Institute for Policy Innovation (IPI) on June 9th for our special luncheon with former Senator Phil Gramm to discuss his new book, The Triumph of Economic Freedom, released May 13.

Because the problem, as always, is spending. Federal revenue grows at a remarkably steady pace. It’s reasonably predictable. But there is no political will to control spending, and that includes President Trump, who urged Republicans against further spending cuts.

Consumers should have the right to resell tickets on secondary markets.

Implementing MFN for Medicaid drug reimbursement would be a long-term structural disaster in exchange for perceived short-term benefits. There are better ways to address our entitlements crisis, and Congress should pursue them.

Secondary markets are an important component of a free market, and if you buy a legitimate ticket to a live event, you should be able to transfer it to whomever you choose, however you choose. But the Ticketmaster/Live Nation demogorgon wants to control that as well.